OIE Reference Laboratory Reports Activities Activities in 2015

This report has been submitted : 2016-01-19 11:55:58

Name of disease (or topic) for which you are a designated OIE Reference Laboratory:

Infectious bursal disease (Gumboro disease)

Address of laboratory:

Avian and Rabbit Virology Immunology and Parasitology Unit (VIPAC) French Agency for Food, Environmental and Occupational Heath Safety (ANSES) B.P. 53 22440 Ploufragan-Plouzané FRANCE

Tel.:

+33 (0)2 96 01 62 22

Fax:

+33 (0)2 96 01 62 63

E-mail address:

[email protected]

Website:

Name (including Title) of Head of Laboratory (Responsible Official):

Dr Gilles SALVAT

Name (including Title and Position) of OIE Reference Expert:

Dr Nicolas Eterradossi

Which of the following defines your laboratory? Check all that apply:

Governmental Research

OIE Reference Laboratory Reports Activities, 2015

1

Infectious bursal disease (Gumboro disease) - Nicolas Eterradossi - france

ToR 1: To use, promote and disseminate diagnostic methods validated according to OIE Standards

1. Did your laboratory perform diagnostic tests for the specified disease/topic for purposes such as disease diagnosis, screening of animals for export, surveillance, etc.? (Not for quality control, proficiency testing or staff training) Yes

Diagnostic Test

Indicated in OIE Manual (Yes/No)

Indirect diagnostic tests

Total number of test performed last year

Nationally

Internationally

Agar Gel ImmunoDiffusion

Yes

1314

20

Virus neutralization test in CEF

Yes

358

20

Nationally

Internationally

Direct diagnostic tests Virus isolation or titration in eggs

Yes

18

2

Virus isolation or titration in CEF

Yes

154

0

Preparation of virus stocks from infected bursae

Yes

7

12

Detection of IBDV by antigen Capture ELISA

Yes

0

8

Partial amplification of IBDV genome (RT-PCR for VP2 or VP1 gene)

Yes

68

0

Quantification of IBDV genome by qRT-PCR

No

5

ToR 2: To develop reference material in accordance with OIE requirements, and implement and promote the application of OIE Standards. To store and distribute to national laboratories biological reference products and any other reagents used in the diagnosis and control of the designated pathogens or disease.

2. Did your laboratory produce or supply imported standard reference reagents officially recognised by the OIE? No 3. Did your laboratory supply standard reference reagents (non OIE-approved) and/or other diagnostic reagents to OIE Member Countries?

2

OIE Reference Laboratory Reports Activities, 2015

Infectious bursal disease (Gumboro disease) - Nicolas Eterradossi - france Yes

OIE Reference Laboratory Reports Activities, 2015

3

Infectious bursal disease (Gumboro disease) - Nicolas Eterradossi - france

Type of reagent available

Reference viral stock of classical virulent IBDV (F52/70)

Related diagnostic test

Produced/ provide

Amount supplied nationally (ml, mg)

Amount supplied internationally (ml, mg)

No. of recipient OIE Member Countries

Region of recipients

Africa America s Vaccine Challenge

provided

0mL

1.5mL

1

Asia and Pacific Europe Middle East Africa America

Reference viral stock of very virulent IBDV (89163)

anti-IBDV polyclonal serum (positive control)

anti-IBDV polyclonal serum (positive control)

s Vaccine Challenge

provided

0mL

1.5mL

1

Asia and Pacific Europe Middle East Africa America s

VN test

Provided

2mL

2mL

2

Asia and Pacific Europe Middle East Africa America s

Agar gel immunodiffusion

Provided

1mL

0

1

Asia and Pacific Europe Middle East Africa America s

inactivated antigen

Reference viral stock of attenuated, cell-culture adapted IBDV strain (strain CT)

4

Agar gel immunodiffusion

Provided

4mL

0

1

Asia and Pacific Europe Middle East Africa America s

virus titration , VN test

Provided

1.5mL

1

Asia and Pacific Europe Middle East

OIE Reference Laboratory Reports Activities, 2015

Infectious bursal disease (Gumboro disease) - Nicolas Eterradossi - france Africa America Panel of sera containing or not anti-IBDV antibodies

Proficiency testing in VN test and AGID

s Provided

7.5mL

1

Asia and Pacific Europe Middle East

4. Did your laboratory produce vaccines? No

5. Did your laboratory supply vaccines to OIE Member Countries? No

ToR 3: To develop, standardise and validate, according to OIE Standards, new procedures for diagnosis and control of the designated pathogens or diseases

6. Did your laboratory develop new diagnostic methods validated according to OIE Standards for the designated pathogen or disease? Yes 7. Did your laboratory develop new vaccines according to OIE Standards for the designated pathogen or disease? No

Name of the new test or diagnostic method or vaccine developed

Description and References (Publication, website, etc.)

Update of oligonucleotide primers for RT-PCR detection of IBDV genome segments A (VP2 gene) and B (VP1 gene).

In progress

ToR 4: To provide diagnostic testing facilities, and, where appropriate, scientific and technical advice on disease control measures to OIE Member Countries

8. Did your laboratory carry out diagnostic testing for other OIE Member Countries? Yes

OIE Reference Laboratory Reports Activities, 2015

5

Infectious bursal disease (Gumboro disease) - Nicolas Eterradossi - france

Name of OIE Member Country seeking assistance

Date (month)

No. samples received for provision of diagnostic support

No. samples received for provision of confirmatory diagnoses

SPAIN

07/2015

2

0

ALGERIA

11/2015

35

35

9. Did your laboratory provide expert advice in technical consultancies on the request of an OIE Member Country? No

ToR 5: To carry out and/or coordinate scientific and technical studies in collaboration with other laboratories, centres or organisations

10. Did your laboratory participate in international scientific studies in collaboration with OIE Member Countries other than the own? Yes

Title of the study

Duration

Purpose of the study

Partners (Institutions)

OIE twinning

3 years

Harmonization of methods for the identification and characterization of IBDV strains, joint research on emerging IBDV strains

Harbin veterinary Research Institute

Epidemiology of IBDV in Algeria (PhD Thesis)

15 months

see title

Ecole Nationale Supérieure Vétérinaire Alger

ToR 6: To collect, process, analyse, publish and disseminate epizootiological data relevant to the designated pathogens or diseases

11. Did your Laboratory collect epizootiological data relevant to international disease control? No 12. Did your laboratory disseminate epizootiological data that had been processed and analysed? No

13. What method of dissemination of information is most often used by your laboratory? (Indicate in the appropriate box the number by category) a) Articles published in peer-reviewed journals: 0

6

OIE Reference Laboratory Reports Activities, 2015

Infectious bursal disease (Gumboro disease) - Nicolas Eterradossi - france b) International conferences: 4 ETERRADOSSI N., SOUBIES, S.M., BRIAND F.X. , BROWN P.A. (2015) Technical and Biological Issues in Genotyping Widespread Avian Viruses: Some Examples From IBDV, IBV and Avian Metapneumovirus (AMPV) Research. . North Central Avian Disease Conference. 17 march 2015, Saint Paul, MN, USA S. Soubies, C. Courtillon, F.X. Briand, N. Eterradossi : The role of both genome segments in the epidemiology and pathogenicity of IBDV. Winter meeting of British Veterinary Poultry Association (BVPA), Manchester, UK, 12 novembre 2015. C. Le Nouën, S. Soubies, P. Cruz, M. Dolan, O. Guionie, D. Toquin, C. Courtillon and N. Eterradossi. Polymerase stuttering: a previously unrecognized molecular mechanism contributing to genetic variation in infectious bursal disease virus. First Global Alliance for Research on Avian Diseases (GARAD) Conference, Londres, 30 juin 2015. K. Li, C. Courtillon, O. Guionie, C. Allée, M. Amelot, X. Qi, Y. Gao, X. Wang, N. Eterradossi : Genetic, antigenic and pathogenic characterization of infectious bursal disease viruses isolated in China. World Veterinary Poultry Association Congress, 2015, Cape Town, South Africa 7-11 Septembre 2015.

S. M. Soubies, O. Guionie, C. Courtillon, FX- Briand, M. Queguiner, K. Grousson, P. Morillon, JB. Herin, M. Amelot, A. Keita and N. Eterradossi : Isolation, genetic characterization and pathotyping of a European interserotypic reassortant of IBDV. World Veterinary Poultry Association Congress, 2015, Cape Town, South Africa 7-11 Septembre 2015. c) National conferences: 2 C. le Nouen, S. M. Soubies, P. Cruz, M. A Dolan, O. Guionie, D. Toquin, C. Courtillon, N.Eterradossi. Insertion spontanée d’un acide aminé dans le domaine projeté de la protéine de capside de l’avibirnavirus de la bursite infectieuse aviaire : conséquences antigéniques et biologiques. Journées Francophones de Virologie, 9-10 avril 2015. S. Soubies, N. Eterradossi : Epidémiologie moléculaire comparée des deux segments du génome du virus de la bursite infectieuse du poulet et pouvoir pathogène viral. Journées scientifiques des laboratoires de l’ANSES, 18 novembre 2015, Maisons-Alfort. d) Other: (Provide website address or link to appropriate information) 0

ToR 7: To provide scientific and technical training for personnel from OIE Member Countries To recommend the prescribed and alternative tests or vaccines as OIE Standards

14. Did your laboratory provide scientific and technical training to laboratory personnel from other OIE Member Countries? Yes a) Technical visits: 1 b) Seminars: 0 c) Hands-on training courses: 1 d) Internships (>1 month): 1

OIE Reference Laboratory Reports Activities, 2015

7

Infectious bursal disease (Gumboro disease) - Nicolas Eterradossi - france Type of technical training provided (a, b, c or d)

Country of origin of the expert(s) provided with training

No. participants from the corresponding country

c

PR China

2

d

Algeria

1

a

United-Kingdom

1

ToR 8: To maintain a system of quality assurance, biosafety and biosecurity relevant for the pathogen and the disease concerned

15. Does your laboratory have a Quality Management System certified according to an International Standard? Yes

Quality management system adopted

Certificate scan (PDF, JPG, PNG format)

NF EN ISO/CEI 17025

Attestion management qualité VIPAC anglais rapport 2015.pdf

16. Is your laboratory accredited by an international accreditation body? No 17. Does your laboratory maintain a “biorisk management system” for the pathogen and the disease concerned? No (See Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 2014, Chapter 1.1.3a)

ToR 9: To organise and participate in scientific meetings on behalf of the OIE

18. Did your laboratory organise scientific meetings on behalf of the OIE? No

19. Did your laboratory participate in scientific meetings on behalf of the OIE? No

8

OIE Reference Laboratory Reports Activities, 2015

Infectious bursal disease (Gumboro disease) - Nicolas Eterradossi - france

ToR 10: To establish and maintain a network with other OIE Reference Laboratories designated for the same pathogen or disease and organise regular inter-laboratory proficiency testing to ensure comparability of results

20. Did your laboratory exchange information with other OIE Reference Laboratories designated for the same pathogen or disease? Yes 21. Was your laboratory involved in maintaining a network with OIE Reference Laboratories designated for the same pathogen or disease by organising or participating in proficiency tests? No

22. Did your laboratory collaborate with other OIE Reference Laboratories for the same disease on scientific research projects for the diagnosis or control of the pathogen of interest? Yes

Title of the project or contract

Scope

Name(s) of relevant OIE Reference Laboratories

Tackling virus-induced immunosuppression in the Mediterranean

Writing proposal in answer of the European call ARIMnet2 (selected at first step, rejected at final selection step).

Ohio state Univeristy (Pr. Mo SAIF)

ToR 11: To organise inter-laboratory proficiency testing with laboratories other than OIE Reference Laboratories for the same pathogens and diseases to ensure equivalence of results

23. Did your laboratory organise or participate in inter-laboratory proficiency tests with laboratories other than OIE Reference Laboratories for the same disease? Yes Note: See Interlaboratory test comparisons in: Laboratory Proficiency Testing at: http://www.oie.int/en/our-scientific-expertise/reference-laboratories/proficiency-testing see point 1.3

Purpose for inter-laboratory test comparisons1

Harmonization of IBDV diagnostic methods in the context of OIE twinning

OIE Reference Laboratory Reports Activities, 2015

No. participating laboratories

2

Region(s) of participating OIE Member Countries Africa Americas Asia and Pacific Europe Middle East

9

Infectious bursal disease (Gumboro disease) - Nicolas Eterradossi - france

ToR 12: To place expert consultants at the disposal of the OIE

24. Did your laboratory place expert consultants at the disposal of the OIE? No

25. Additional comments regarding your report:

10

OIE Reference Laboratory Reports Activities, 2015